Vanguard Group
BLU

Vanguard Group’s BELLUS Health Inc. BLU Stock Holding History

Vanguard Group’s Portfolio BLU Stock Details BLU Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q2 		– Sell
-55,975
Closed -$403K – 4586
2023
Q1 		$403K Hold
55,975
– – ﹤0.01% 4179
2022
Q4 		$460K Buy
55,975
+7,915
+16% +$73.8K ﹤0.01% 4120
2022
Q3 		$508K Buy
48,060
+10,400
+28% +$111K ﹤0.01% 4204
2022
Q2 		$348K Buy
+37,660
New +$308K ﹤0.01% 4369
2020
Q4 		– Sell
-25,215
Closed -$57K – 4226
2020
Q3 		$57K Hold
25,215
– – ﹤0.01% 4059
2020
Q2 		$259K Buy
+25,215
New +$256K ﹤0.01% 3889

Other funds holding BLU

CG
Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return
VAM
Vazirani Asset Management New York $43.4M AUM 84.05% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $416B AUM 33.63% 1-Year Est. Return
GLAM
Gardner Lewis Asset Management Chadds Ford, Pennsylvania $462M AUM 65.29% 1-Year Est. Return
Simplex Trading
Simplex Trading Chicago, Illinois $149B AUM 62.07% 1-Year Est. Return
Amundi
Amundi Paris, France $367B AUM 31.23% 1-Year Est. Return
SAM
Shell Asset Management The Hague, Netherlands $996M AUM 26.19% 1-Year Est. Return
Canada Life
Canada Life Winnipeg, Manitoba, Canada $55.8B AUM 26.04% 1-Year Est. Return
CUAMC
China Universal Asset Management Company Shanghai, China $1.32B AUM 51.82% 1-Year Est. Return
LC
Lindbrook Capital Calabasas, California $1.08B AUM 10.14% 1-Year Est. Return

Vanguard Group's BLU Position: Q2 2023 in Review

Vanguard Group sold out of BELLUS Health Inc. (BLU) in Q2 2023, closing a stake of 55,975 shares — an estimated $403K sold.

Vanguard Group first reported a position in BLU in Q2 2020 and held it in 6 quarters. The position peaked at $508K in Q3 2022. 11 funds tracked by Wall St. Rank hold BLU as of Q2 2023.

  • Vanguard Group reported no remaining BELLUS Health Inc. position as of Q2 2023 after selling out during the quarter.
  • Vanguard Group sold 55,975 BELLUS Health Inc. shares in Q2 2023, an estimated $403K.
  • Vanguard Group first reported a position in BELLUS Health Inc. in Q2 2020 and held it in 6 quarters.
  • Vanguard Group's BELLUS Health Inc. position peaked at $508K in Q3 2022.
  • 11 funds tracked by Wall St. Rank held BELLUS Health Inc. as of Q2 2023.

Based on Vanguard Group's 13F filing for Q2 2023, filed 14 Aug 2023.